FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| BPI Labs LLC | 078627620 | 54288-831 | 54288-831-25 | Semaglutide | 12.5 mg/2.5 mL | 2025-1 | valid | 2026-10-06 | |
| BPI Labs LLC | 54288-831 | 54288-831-25 | Semaglutide Injection, 12.5 mg/2.5 mL (5 mg/mL) | Semaglutide Injection, 12.5 mg/2.5 mL (5 mg/mL) | 12.5 mg/2.5 mL | 2025-1 | valid | 2026-09-18 | |
| BPI Labs LLC | 078627620 | 54288-831 | 54288-831-25 | Semaglutide | 12.5 mg/2.5 mL | 2024-2 | valid | 2026-10-06 | |
| BPI Labs LLC | 54288-831 | 54288-831-25 | Semaglutide Injection, 12.5 mg/2.5 mL (5 mg/mL) | Semaglutide Injection, 12.5 mg/2.5 mL (5 mg/mL) | 12.5 mg/2.5 mL | 2024-2 | valid | 2026-09-18 | |
| BPI Labs LLC | 078627620 | 54288-831 | 54288-831-01 | Semaglutide | 12.5 mg/2.5 mL | 2024-1 | valid | 2026-10-06 |